Paulo Zortea, MD
Vascular Neurology · Greenville, SCNPI 1629057534
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations.
Across 19 payments — averaging $16.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$46
- Sunovion Pharmaceuticals Inc.$35
- Catalyst Pharmaceuticals, Inc.$29
- CSL Behring$25
- Acadia Pharmaceuticals Inc$23
- Sanofi$22
- plus $132 from 8 others
What the payments were for
- Food & beverage$313100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 3 | $46 |
| Sunovion Pharmaceuticals Inc. | 2 | $35 |
| Catalyst Pharmaceuticals, Inc. | 2 | $29 |
| CSL Behring | 1 | $25 |
| Acadia Pharmaceuticals Inc | 2 | $23 |
| Sanofi | 1 | $22 |
| Merz North America, Inc. | 1 | $21 |
| Amgen | 1 | $19 |
| Biogen | 1 | $19 |
| Mallinckrodt Enterprises LLC | 1 | $17 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Ipsen Biopharmaceuticals, Inc | 1 | $16 |
| Upsher-smith Laboratories LLC | 1 | $13 |
| AbbVie | 1 | $11 |
How this compares
Too few vascular neurology providers in South Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Divalproex Sodium ErDivalproex Sodium | 15 | $181 |
| Memantine Hcl | 12 | $130 |
Paid to pharmacies, not to this prescriber.
Other vascular neurology in Greenville
- Abraham ThomasGreenville$221
- Joseph HannaGreenville$72
- David LockwoodGreenville$17
- Souvik SenColumbia$12K
- Anil YallapragadaCharleston$7K
- Line Abdul RahmanCharleston$324
- Forrest LoweCharleston$157
- Sandeep GillColumbia$105
- Ravish KothariColumbia$38
- Rodney LeacockColumbia$12
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.